Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/1dd3c0f0-fd4e-4e4b-a276-ed4392d3ae8e/

POM

POMDOCTOR LIMITED American Depositary Shares
Chart
0.71 USD
Latest Week 2026-07-24
HealthcarePharmaceutical RetailersNANO
Snapshot 2026-07-26 · 0.7w · Fresh
0.44
OS Score
46.0%
Value
45.0%
Quality
47.0%
Momentum
4/9
F-Score
0.455
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
46.0%ile
P/S
0.0×
FCF Yield
-0.309
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
54.00000000
/100 — 1=cheapest
VC2 (Trending Value)
55.00000000
/100
VC3 (Buyback)
55.00000000
/100
Negative FCF yield (-30.9%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
45.0%ile
ROE
0.468
ROA
-1.976
Net Margin
-0.532
Op Margin
-0.295
GPA
0.486
D/E
-1.30
Current
0.48
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.167
Accruals
-0.596
lower=better
5yr Consist
No
ROE of 47% is exceptional. Conservative balance sheet with D/E of -1.30.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
47.0%ile
6M Return
-86.3%
Vol 252d
199.7%
Vol 60d
452.2%
↑ Expanding
Max DD 12M
-99.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (452%) is expanding vs long-term (200%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.44
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
14.0%
Sector Quality %ile
14.0%
Sector Avg OS
64.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIO Fortress Biotech Inc 99.0% 98.0% 84.0% 87.0%
NUTX Nutex Health Inc 99.0% 93.0% 98.0% 87.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 97.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 90.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 99.0% 92.0% 93.0% 92.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 86.0%
CGEN Compugen 98.0% 90.0% 96.0% 83.0%
MD Mednax Inc 97.0% 86.0% 84.0% 94.0%
Factor Interactions
Volatility Expanding
60-day vol (452%) significantly exceeds 252-day (200%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
50.0% avg (2 factors)
Quality
C
49.6% avg (8 factors)
Momentum
F
0.0% avg (1 factors)
Risk
F
0.0% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.440—0—
Value %ile0.460—0—
Quality %ile0.450—0—
Momentum %ile0.470—0—
F-Score4.000—8—
Confidence0.552—0—
Volatility1.997—8—
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
0.01
FCF Yield
-30.9%
Sales Yield (1/P·S)
0.8367
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
46.8%
Return on Assets
-197.6%
Net Margin
-53.2%
Operating Margin
-29.5%
Gross Profit / Assets
Novy-Marx GPA
48.6%
Debt / Equity
-1.30
Current Ratio
0.48
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.596
MomentumPrice trend strength over different horizons
6M Return
-86.3%
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
16.7%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
54
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
55
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
55
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity